王娟红, 黄高昇, 杨国嵘, 郭英, 冯骥良, 王哲, 梁蓉. 恶性组织细胞增生症临床病理及免疫表型研究[J]. 中国肿瘤临床, 2004, 31(9): 502-505.
引用本文: 王娟红, 黄高昇, 杨国嵘, 郭英, 冯骥良, 王哲, 梁蓉. 恶性组织细胞增生症临床病理及免疫表型研究[J]. 中国肿瘤临床, 2004, 31(9): 502-505.
Wang Juan-hong, Huang Gao-sheng, Yang Guo-rong, . A Clinicopathologic and Immunophenotypic Study of so called Malignant Histiocytosis[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(9): 502-505.
Citation: Wang Juan-hong, Huang Gao-sheng, Yang Guo-rong, . A Clinicopathologic and Immunophenotypic Study of so called Malignant Histiocytosis[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(9): 502-505.

恶性组织细胞增生症临床病理及免疫表型研究

A Clinicopathologic and Immunophenotypic Study of so called Malignant Histiocytosis

  • 摘要: 目的:探讨恶性组织细胞增生症的临床病理特征和组织学分型;研究其肿瘤细胞来源及其与EB病毒感染之间的关系。方法:对以往根据临床和形态学特征诊断的13例恶性组织细胞增生症进行临床病理和免疫组织化学研究。结果:1)根据组织学特征13例恶性组织细胞增生症可分为三型:中-小淋巴样细胞型7例;异型组织细胞型5例;霍奇金样型1例。2)免疫组织化学研究结果13例恶性组织细胞增生症中,9例T细胞性淋巴瘤(CD45RO阳性),2例组织细胞性肿瘤(CD68阳性),1例杂合表达(CD45RO和CD68同时阳性),1例T细胞源性间变性大细胞淋巴瘤(CD45RO、EMA和CD30阳性),无一例B细胞性或NK细胞性肿瘤(CD20和CD56全部阴性)。3)13例恶性组织细胞增生症中,LMP-1阳性者共7例(7/13),其中T细胞源性5例(5/9),组织细胞源性1例(1/2),间变性大细胞性淋巴瘤1例(1/1)。结论:1)恶性组织细胞增生症的组织形态学分型对判断其细胞来源具有一定的临床病理意义。2)恶性组织细胞增生症实为异源性恶性肿瘤,来源于组织细胞的恶性肿瘤极少,诊断应严格掌握标准。3)部分恶性组织细胞增生症病例的发生与EB病毒感染有关。

     

    Abstract: Objective: To investigate the clinicopathologic features and histopathologic types of the so called malignant histiocytosis (MH) and to investigate its cell origin and relation with Epstein-Barr virus. Methods: Paraffin sections of 13 cases of M H diagnosed previously based on clinical and morphologic features were analyzed with morphological and immunohistochemical methods. Results:Based on the morphological features, 13 cases of M H can be divided into three types: Medium-small sized lymphoid cell type; Atypical histiocytes type; Hodgkin's -like type. The immunohistochemical study of 13 cases showed 9 cases of T-cell lymphoma that expressed CD45R0, 2 cases of histiocytic lymphoma that expressed CD68, and 1 case of hybrid form (CD45R0 and CD68 coexpressed), 1 case of anaplastic large cell lymphoma that expressed CD45R0, EMA, and CD30, none of them originated from B or 5K-cell that expressed CD20 or CD56. 0f the 13 cases MH, there were 7 cases expressed L M P -1, in which 5 cases belonged to T-cell lymphoma (5/9), 1 case histiocytic origin (1/2) and 1 case anaplastic large cell lymphoma. Conclusions: Classifying M H by histological features is important in clinic pathology for identifying the cell origin of tumor. The so called malignant histiocytosis, in fact, is a group of malignant heterogeneous tumors. The true histiocytic origin is believed extremely rare and the diagnosis oi it should be based on the very strict standard. Some of the malignant histiocytosis shows a relationship with E B : infection.

     

/

返回文章
返回